Let’s Reach Your Development Milestones Together

Dr. Marcus Mreyen, PhD

Director, Business Development, Central Europe

Marcus Mreyen holds a PhD in chemistry and spent two years in the protein analytical field at Macquarie University and the Australian Proteome Analysis Facility (APAF). Starting at Protagen AG in 2000, he successfully worked as a Project Manager and supported multiple customer projects in the various fields of protein characterization. He transferred and deepened his technical understanding while working for Shimadzu Europe, as a Product Manager for Mass Spectrometry and Life Science products. During this time, he assisted customers in pharma and biotech in Europe and Russia, before returning in 2013 to ProtaGene as a Head for Business Development.

Since then, he has supported a large variety of international companies in their Biosimilar or NBE developments from early phases of development to Phase 3, as well as for GMP release and stability testing.

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Biologic Therapeutics
Platform Expertise

  • bullet Created with Sketch.

    mAbs

  • bullet Created with Sketch.

    Bispecifics/Multispecifics

  • bullet Created with Sketch.

    Recombinant Proteins—Including Complex, Highly Glycosylated Proteins

  • bullet Created with Sketch.

    Multi-subunit Complexes—Protein, Nucleotide, Ligand

  • bullet Created with Sketch.

    Fusion Proteins

  • bullet Created with Sketch.

    Enzyme Replacement Therapies

  • bullet Created with Sketch.

    ADCs and Protein Conjugates

  • bullet Created with Sketch.

    PEGylated Proteins

  • bullet Created with Sketch.

    Biosimilars

  • bullet Created with Sketch.

    Vaccines, Including Subunit/Recombinant

Cell and Gene Therapeutic Platform Expertise

  • bullet Created with Sketch.

    Capsid-based Vectors

  • bullet Created with Sketch.

    Complex, Envelope Vectors

  • bullet Created with Sketch.

    Non-viral Vectors

  • bullet Created with Sketch.

    Genetic Engineering